Bioventus (BVS) Change in Working Capital (2020 - 2022)
Bioventus (BVS) posted Change in Working Capital of $1.1 million for Q2 2022, up 59.27% on a QoQ basis from $712000.0 in Q4 2021, and down 87.62% year-over-year from $9.2 million in Q2 2021.
Bioventus (BVS) Change in Working Capital (2020 - 2022) Analysis & Trends
Bioventus' Change in Working Capital history runs 3 years deep, the most recent figure standing at $1.1 million for Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.24 Bn | 6.27 Bn | - |
| 2 | Stryker | 129.03 Bn | 126.15 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.43 Bn | 99.21 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.74 Bn | 67.28 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.78 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | -128.78 Mn |
| 10 | Bioventus | 824.72 Mn | 788.87 Mn | 90.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 2, 2022 | 1.13 Mn |
| Apr 2, 2022 | 1.13 Mn |
| Oct 2, 2021 | 712,000.00 |
| Oct 2, 2021 | 712,000.00 |
| Jul 3, 2021 | 3.85 Mn |
| Jul 3, 2021 | 3.85 Mn |
| Apr 3, 2021 | 9.16 Mn |
| Apr 3, 2021 | 9.16 Mn |
| Sep 26, 2020 | -2.80 Mn |
| Sep 26, 2020 | -2.80 Mn |
| Jun 27, 2020 | 1.24 Mn |
| Jun 27, 2020 | 1.24 Mn |
| Mar 28, 2020 | -369,000.00 |
| Mar 28, 2020 | -369,000.00 |